What is Collplant Biotechnologies Ltd (CLGN) stock price today?

Collplant Biotechnologies Ltd (CLGN) currently trades at $0.37 per share. The stock has a market capitalization of $6.00M and a P/E ratio of —x.

Is CLGN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Collplant Biotechnologies Ltd has a Smart Value Score of 28/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Collplant Biotechnologies Ltd's revenue and earnings?

Collplant Biotechnologies Ltd has trailing twelve-month (TTM) revenue of $2.37M with profit margins of 0.00%. Earnings per share (EPS) is $-0.94.

CLGN

Collplant Biotechnologies Ltd

NASDAQ: CLGN · HEALTHCARE · BIOTECHNOLOGY

$0.37

-4.51% today

Updated 2026-04-29

Market cap

$6.00M

P/E ratio

—

P/S ratio

2.53x

EPS (TTM)

$-0.94

Dividend yield

—

52W range

$0 – $5

Volume

0.1M

Market cap

$6.00M

P/E ratio

—

P/S ratio

2.53x

EPS (TTM)

$-0.94

Dividend yield

—

52W range

$0 – $5

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$11.12

+2885.23%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-3.23M

- Revenue declining -63.40% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$299000.00	$10.96M	$515000.00	$2.37M	$2.37M
Net income	$-16.93M	$-7.02M	$-16.61M	$-11.49M	$-3.21M
EPS	—	—	—	—	$-0.94
Free cash flow	$-14.97M	$-3.72M	$-14.58M	$-9.45M	$-3.23M
Profit margin	-5,660.54%	-64.05%	-3,225.05%	-484.56%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CLGN	$6.00M	28	5.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Collplant Biotechnologies Ltd trades at $0.37. Our Smart Value Score of 28/100 indicates the stock is weak. TTM revenue stands at $2.37M.

Frequently asked questions

What is Collplant Biotechnologies Ltd's stock price?

Collplant Biotechnologies Ltd (CLGN) trades at $0.37.

Is Collplant Biotechnologies Ltd overvalued?

Smart Value Score 28/100 (Grade F, Strong Sell).

What is the price target of Collplant Biotechnologies Ltd (CLGN)?

The analyst target price is $11.12, representing +2885.2% upside from the current price of $0.37.

What is Collplant Biotechnologies Ltd's revenue?

TTM revenue is $2.37M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2.53x

ROE-117.60%

Beta0.94

50D MA$0.54

200D MA$1.72

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CLGN vs LLY →CLGN vs JNJ →CLGN vs ABBV →Stock screener →